Screener
Regenxbio RGNX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 98,452 | 104,855 |
| Operating lease right-of-use assets | 43,867 | 47,156 |
| Restricted cash | 1,805 | 2,030 |
| Other assets | 5,902 | 4,613 |
| Total assets | $386,618 | $453,032 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $15,546 | $21,358 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's other non-current assets?
- Regenxbio (RGNX) reported other non-current assets of $5.9M in Q2 2026.
- How has Regenxbio's other non-current assets changed year-over-year?
- Regenxbio's other non-current assets increased by 214.1% year-over-year, from $1.88M to $5.9M.
- What is the long-term trend for Regenxbio's other non-current assets?
- Over 5 years (2020 to 2025), Regenxbio's other non-current assets has grown at a -2.7% compound annual growth rate (CAGR), from $5.28M to $4.61M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Regenxbio's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude